Andrew Mok
Stock Analyst at Barclays
(3.45)
# 894
Out of 5,165 analysts
274
Total ratings
52.11%
Success rate
2.01%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGRY Surgery Partners | Maintains: Equal-Weight | $18 → $14 | $12.65 | +10.67% | 6 | Mar 3, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Equal-Weight | $14 → $20 | $23.73 | -15.72% | 21 | Mar 3, 2026 | |
| AGL agilon health | Maintains: Underweight | $1 → $0.5 | $0.61 | -18.57% | 6 | Feb 27, 2026 | |
| UHS Universal Health Services | Maintains: Overweight | $262 → $268 | $193.46 | +38.53% | 27 | Feb 26, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $245 → $176 | $170.77 | +3.06% | 16 | Feb 25, 2026 | |
| ADUS Addus HomeCare | Maintains: Underweight | $117 → $112 | $101.52 | +10.32% | 5 | Feb 24, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $598 → $635 | $509.87 | +24.54% | 18 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Overweight | $240 → $257 | $211.64 | +21.43% | 17 | Feb 13, 2026 | |
| MOH Molina Healthcare | Maintains: Underweight | $164 → $133 | $143.96 | -7.61% | 12 | Feb 10, 2026 | |
| EHC Encompass Health | Maintains: Overweight | $150 → $153 | $101.57 | +50.64% | 19 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $305 → $303 | $263.47 | +15.00% | 11 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $186 → $190 | $149.98 | +26.68% | 15 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $18 | $14.55 | +23.71% | 3 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $391 → $327 | $287.57 | +13.71% | 15 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $404 → $393 | $295.75 | +32.88% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $9 → $11 | $7.07 | +55.59% | 3 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $13 → $18 | $13.51 | +33.23% | 4 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $44 → $54 | $34.94 | +54.55% | 13 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $93 | $74.81 | +24.31% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $36 → $26 | $24.80 | +4.84% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $79 → $86 | $63.63 | +35.16% | 9 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $23 | $22.10 | +4.07% | 10 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $18 | $17.92 | +0.45% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $3.5 | $3.11 | +12.54% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $13.62 | -11.89% | 1 | Dec 8, 2022 |
Surgery Partners
Mar 3, 2026
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $12.65
Upside: +10.67%
Acadia Healthcare Company
Mar 3, 2026
Maintains: Equal-Weight
Price Target: $14 → $20
Current: $23.73
Upside: -15.72%
agilon health
Feb 27, 2026
Maintains: Underweight
Price Target: $1 → $0.5
Current: $0.61
Upside: -18.57%
Universal Health Services
Feb 26, 2026
Maintains: Overweight
Price Target: $262 → $268
Current: $193.46
Upside: +38.53%
Humana
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $245 → $176
Current: $170.77
Upside: +3.06%
Addus HomeCare
Feb 24, 2026
Maintains: Underweight
Price Target: $117 → $112
Current: $101.52
Upside: +10.32%
HCA Healthcare
Feb 23, 2026
Maintains: Buy
Price Target: $598 → $635
Current: $509.87
Upside: +24.54%
Tenet Healthcare
Feb 13, 2026
Maintains: Overweight
Price Target: $240 → $257
Current: $211.64
Upside: +21.43%
Molina Healthcare
Feb 10, 2026
Maintains: Underweight
Price Target: $164 → $133
Current: $143.96
Upside: -7.61%
Encompass Health
Feb 6, 2026
Maintains: Overweight
Price Target: $150 → $153
Current: $101.57
Upside: +50.64%
Feb 6, 2026
Maintains: Overweight
Price Target: $305 → $303
Current: $263.47
Upside: +15.00%
Feb 4, 2026
Maintains: Buy
Price Target: $186 → $190
Current: $149.98
Upside: +26.68%
Feb 3, 2026
Maintains: Overweight
Price Target: $15 → $18
Current: $14.55
Upside: +23.71%
Jan 30, 2026
Maintains: Overweight
Price Target: $391 → $327
Current: $287.57
Upside: +13.71%
Jan 30, 2026
Maintains: Overweight
Price Target: $404 → $393
Current: $295.75
Upside: +32.88%
Jan 16, 2026
Maintains: Overweight
Price Target: $9 → $11
Current: $7.07
Upside: +55.59%
Jan 5, 2026
Upgrades: Equal-Weight
Price Target: $13 → $18
Current: $13.51
Upside: +33.23%
Jan 5, 2026
Upgrades: Overweight
Price Target: $44 → $54
Current: $34.94
Upside: +54.55%
Dec 10, 2025
Maintains: Overweight
Price Target: $87 → $93
Current: $74.81
Upside: +24.31%
Nov 24, 2025
Maintains: Equal-Weight
Price Target: $36 → $26
Current: $24.80
Upside: +4.84%
Nov 13, 2025
Maintains: Overweight
Price Target: $79 → $86
Current: $63.63
Upside: +35.16%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $22 → $23
Current: $22.10
Upside: +4.07%
Nov 3, 2025
Maintains: Equal-Weight
Price Target: $13 → $18
Current: $17.92
Upside: +0.45%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $4 → $3.5
Current: $3.11
Upside: +12.54%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $13.62
Upside: -11.89%